R&D Toolboxes

iBET’s extensive RD&I pipeline encompasses several stages of Omics studies, from sample preparation and data analysis to biological interpretation.

This is supported by over 30+ years of experience in bioprocess and analytics development for the production of Biopharmaceuticals, ATMPs (including gene and cell-based therapies), and Vaccines.

We currently develop projects with Proteomics, Metabolomics & Fluxomics, and Transcriptomics.

iBET’s Late-Stage and Bioproduction Unit has over 30 years of experience in advancing integrated bioprocesses and analytical methods for the production, purification and characterization of complex biologics, especially recombinant proteins, gene and cell-based products, and vaccines.

To address the growing demands of the industry, our unit provides tailored solutions for biotechs, CDMOs and large pharmaceutical companies, focusing on Bioprocess and Bioanalytics Development, GMP-compliant Bioprocess Scale-up, and Technology Transfer.